Gastroschisis and pseudoephedrine during pregnancy

Prescrire International

Volumn 13, Issue 72, 2004, Pages 141-143

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ASCORBIC ACID; CHLORPHENIRAMINE; DECONGESTIVE AGENT; DIPHENHYDRAMINE; EPHEDRINE; IBUPROFEN; LORATADINE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENOBARBITAL; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; THEOPHYLLINE; TRIPROLIDINE; VASOCONSTRICTOR AGENT; TERATOGENIC AGENT;

ABDOMINAL WALL CLOSURE; ABDOMINAL WALL DEFECT; ARTICLE; CASE CONTROL STUDY; CLINICAL PRACTICE; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG FORMULATION; DRUG MARKETING; DRUG USE; EVIDENCE BASED MEDICINE; FRANCE; GASTROSCHISIS; HUMAN; INCIDENCE; NEWBORN DISEASE; NONHUMAN; NOSE CONGESTION; PREGNANCY; PRENATAL EXPOSURE; PRESCRIPTION; RISK ASSESSMENT; TERATOGENICITY; CHEMICALLY INDUCED DISORDER; FEMALE; FETOMATERNAL TRANSFUSION; FIRST TRIMESTER PREGNANCY; INFANT; NEWBORN; PREGNANCY COMPLICATION; RISK;

ABNORMALITIES, DRUG-INDUCED; ACETAMINOPHEN; ADRENERGIC AGENTS; CASE-CONTROL STUDIES; DRUGS, NON-PRESCRIPTION; EPHEDRINE; FEMALE; GASTROSCHISIS; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; TERATOGENS; VASOCONSTRICTOR AGENTS;

EID: 16244389325     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Werler MM et al. "Maternal medication use and risks of gastroschisis and small intestinal atresia" Am J Epidemiol 2002; 155 (1): 26-31.
2. "Pseudoephedrine". In: "Martindale The Complete Drug Reference" 33rd ed, The Pharmaceutical Press, London 2002; 1099-1100.
3. French datasheet compendium "Dictionnaire Vidal" Vidal, Issy-les-Moulineaux 2004.
4. Mazzotta P et al. "Treating allergic rhinitis in pregnancy" Drug Saf 1999; 20 (4): 361-375.
5. Zacharisen MC "Rhinitis in children, adolescents, the elderly, and pregnant women" Immunol Allergy Clin North Am 2000; 20 (2): 425-444.
6. Heinonen OP et al. "Drugs affecting the autonomic nervous system". In: "Birth defects and drugs in pregnancy" Publishing Sciences Group, Littleton 1977: 345-356.
7. Aselton P et al. "First-trimester drug use and congenital disorders" Obstet Gynecol 1985; 65 (4): 451-455.
8. Jick H et al. "First-trimester drug use and congenital disorders" Jama 1981; 246 (4): 343-346.
9. Chasnoff IJ et al. "Fetal alcohol effects and maternal cough syrup abuse" Am J Dis Child 1981; 135: 968.
10. Gilbert-Barness E and Drut RM "Association of sympathomimetic drugs with malformations" Vet Hum Toxicol 2000; 42 (3): 168-171.
11. Werler MM et al. "First trimester maternal medications use in relation to gastroschisis" Teratology 1992; 45: 361-367.
12. Werler MM et al. "Association of vasoconstrictive exposures with risks of gastrochisis and small intestinal atresia" Epidemiology 2003; 14 (3): 349-354.
13. Torfs CP et al. "Maternal medications and environmental exposures as risk factors for gastroschisis" Teratology 1996; 54: 84-92.
14. Incaudo GA "The diagnosis and treatment of rhinosinusitis during pregnancy and lactation" Immmunol Allergy Clin North Am 2000 20 (4): 807-830.
15. Luskin AT and Lipkowitz MA "The diagnosis and management of asthma during pregnancy" Immunol Allergy Clin North Am 2000; 20 (4): 745-761.
16. The European Agency for the Evaluation of Medicinal Products - Committee for Proprietary Medicinal Products "Press Release" 21 November 2003. Website http://www.emea.eu.int consulted on 23 November 2003.
17. Prescrire Rédaction "Antalgiques et grossesse première partie: les données" Rev Prescrire 2000; 20 (203): 127-134.